Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C31H44O8 |
| Molecular Weight | 544.6763 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 12 / 12 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CO[C@H]1[C@H](C)O[C@@H](O[C@H]2CC[C@]3(C)[C@H]4CC[C@]5(C)[C@H](CC[C@]5(O)[C@@H]4CCC3=C2)C6=COC(=O)C=C6)[C@H](O)[C@@H]1O
InChI
InChIKey=RKWPZPDLTYBKCL-RVZGXXANSA-N
InChI=1S/C31H44O8/c1-17-27(36-4)25(33)26(34)28(38-17)39-20-9-12-29(2)19(15-20)6-7-23-22(29)10-13-30(3)21(11-14-31(23,30)35)18-5-8-24(32)37-16-18/h5,8,15-17,20-23,25-28,33-35H,6-7,9-14H2,1-4H3/t17-,20-,21+,22-,23+,25-,26+,27-,28-,29-,30+,31-/m0/s1
| Molecular Formula | C31H44O8 |
| Molecular Weight | 544.6763 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 12 / 12 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Meproscillarin is a semisynthetic glycoside for the therapy of cardiac insufficiency. Meproscillarin is a drug with a high bioavailability (about 70%). Meproscillarin is at the only non-renal eliminated, lipophilic and short half-life digitalis and is therefore an ideal, cardiac inotropic agent for use in renal insufficiency. Meproscillarin can be used therapeutically in patients with liver cirrhosis, because a toxic accumulation is not to be expected. The rate of side effects of meproscillarin corresponded to that of other cardiac glycosides.
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/348206
2-3 tablets of 0.25 mg daily
Route of Administration:
Oral
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:36:18 GMT 2025
by
admin
on
Mon Mar 31 18:36:18 GMT 2025
|
| Record UNII |
WYR1723LO7
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C78322
Created by
admin on Mon Mar 31 18:36:18 GMT 2025 , Edited by admin on Mon Mar 31 18:36:18 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
251-493-6
Created by
admin on Mon Mar 31 18:36:18 GMT 2025 , Edited by admin on Mon Mar 31 18:36:18 GMT 2025
|
PRIMARY | |||
|
100000081500
Created by
admin on Mon Mar 31 18:36:18 GMT 2025 , Edited by admin on Mon Mar 31 18:36:18 GMT 2025
|
PRIMARY | |||
|
15942714
Created by
admin on Mon Mar 31 18:36:18 GMT 2025 , Edited by admin on Mon Mar 31 18:36:18 GMT 2025
|
PRIMARY | |||
|
m9255
Created by
admin on Mon Mar 31 18:36:18 GMT 2025 , Edited by admin on Mon Mar 31 18:36:18 GMT 2025
|
PRIMARY | Merck Index | ||
|
1705
Created by
admin on Mon Mar 31 18:36:18 GMT 2025 , Edited by admin on Mon Mar 31 18:36:18 GMT 2025
|
PRIMARY | |||
|
C87688
Created by
admin on Mon Mar 31 18:36:18 GMT 2025 , Edited by admin on Mon Mar 31 18:36:18 GMT 2025
|
PRIMARY | |||
|
4012
Created by
admin on Mon Mar 31 18:36:18 GMT 2025 , Edited by admin on Mon Mar 31 18:36:18 GMT 2025
|
PRIMARY | |||
|
DTXSID101031613
Created by
admin on Mon Mar 31 18:36:18 GMT 2025 , Edited by admin on Mon Mar 31 18:36:18 GMT 2025
|
PRIMARY | |||
|
WYR1723LO7
Created by
admin on Mon Mar 31 18:36:18 GMT 2025 , Edited by admin on Mon Mar 31 18:36:18 GMT 2025
|
PRIMARY | |||
|
C009079
Created by
admin on Mon Mar 31 18:36:18 GMT 2025 , Edited by admin on Mon Mar 31 18:36:18 GMT 2025
|
PRIMARY | |||
|
SUB08758MIG
Created by
admin on Mon Mar 31 18:36:18 GMT 2025 , Edited by admin on Mon Mar 31 18:36:18 GMT 2025
|
PRIMARY | |||
|
CHEMBL2106427
Created by
admin on Mon Mar 31 18:36:18 GMT 2025 , Edited by admin on Mon Mar 31 18:36:18 GMT 2025
|
PRIMARY | |||
|
33396-37-1
Created by
admin on Mon Mar 31 18:36:18 GMT 2025 , Edited by admin on Mon Mar 31 18:36:18 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |